| Overview |
| bsm-60302r |
| PDPK1 Recombinant Antibody |
| IHC-P, IHC-F, IF, ICC/IF |
| Human |
| Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PDPK1 |
| Recombinant |
| IgG |
| 1mg/ml |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 5170 |
| O15530 |
| Cytoplasm, Cell membrane |
| 3 Phosphoinositide Dependent Protein Kinase 1; hPDK 1; hPDK 1; PDK 1; PkB kinase; PkB kinase like gene 1; PkB like 1; PDPK1_HUMAN. |
| Enables 3-phosphoinositide-dependent protein kinase activity; phospholipase activator activity; and phospholipase binding activity. Involved in several processes, including cell surface receptor signaling pathway; regulation of protein kinase activity; and regulation of signal transduction. Acts upstream of or within intracellular signal transduction. Located in cell projection; cytosol; and plasma membrane. Implicated in prostate cancer. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Nov 2021] |
| Application Dilution |
| IHC-P |
=1:200-500 |
| IHC-F |
ICC=1:50 |
| IF |
IF=1:50-100 |
| ICC/IF |
1:50-100 |